In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33316195.
- Also identified by DOI 10.7326/ACPJ202012150-070.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Douros A, Lix LM, Fralick M, et al. <b>Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study.</b> Ann Intern Med. 2020;173:417-25. 32716707.
Medical subject headings
- Diabetes Mellitus, Type 2
- Diabetic Ketoacidosis
- Dipeptidyl-Peptidase IV Inhibitors
- Sodium-Glucose Transporter 2 Inhibitors